3 Insights From Re:Imagine Pharma Marketing 2020
Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020
Brought to you by Momentum Events
On November 9-11, 2020, Re:Imagine Pharma Marketing, virtual conference discussed...
Author Guidelines
The Pharma Marketing Wire is the bi-monthly e-newsletter of the Pharma Marketing Network® (PMN), which features original articles from pharmaceutical marketing experts and industry...
Ep. 012 – Tom Ollerton Podcast Transcript
RJ (PMN): Hi this is RJ Lewis here for another episode of Pharma Marketing Networks Podcast. I have with me today Tom Ollerton from...
Ep. 011 – Stephanie Berez Podcast Transcript
RJ (PMN): Hi this is RJ Lewis your host of the Pharma Marketing Podcast and I'm here today with Stephanie Berez who is the...
Becoming a Woman of Impact: Success Stories from HBA Women of the Year
Sponsored by GSK’s Women’s Leadership Initiative
Recently, the HBA Mid-Atlantic Region held a webinar called, Becoming a Woman of Impact, where four Women of the...
Ep. 009 – Robin Farmanfarmaian Podcast Transcript
Don (PMN): Hello everyone welcome to the Pharma marketing podcast. I'm your host Don Langsdorf and we've got a great guests lined up for...
Top Considerations for Data Protection and Cybersecurity within the Pharmaceutical Industry
The pharmaceutical industry deals with copious amounts of personal data, which means that adequate data protection and cybersecurity are non-negotiable. Even two years after...
Mixing Branded and Unbranded on One Page—Is it Worth the Risk?
A marketer’s decision to take one promotional route over another—branded versus unbranded—is often critical. But what we increasingly see, is that when branded and...
Key Learnings from DHC’s HCP Communication Innovation
Co-Founder of The DHC Group, Mark Bard, held a 20-minute expert panel discussion on HCP Communication Innovation, focusing on how COVID-19 is accelerating the...
COVID-19: Challenges, Innovation, and What’s Ahead in 2021
Below is a Q&A with Mark Bard, Co-Founder of The DHC Group, who offers his insights on the challenges COVID-19 has brought to pharma, as...
